---
title: AAV / Viral Vector Platform CROs
path: /modalities/aav-vector-platform
companies_count: 12
---

# AAV / Viral Vector Platform CROs

12 published CROs match AAV / Viral Vector Platform.

Locations in this set include United States, China, Singapore, Multiple, Netherlands, and South Korea.

Capabilities that show up most often in this set: Translational Research, Analytical Method Development & Validation, In Vivo Efficacy Models, Preclinical In Vivo Studies, and Bioanalysis.

## Matching companies

- [Cellentia, Inc.](/companies/cellentiabio)
  - Specialized contract research organization offering custom bioassays, organoid culturing, AAV and MSD assays, PBMC isolation, and patient-derived 3D tumor organoid lines for drug development and translational research.
- [Charles River Laboratories](/companies/criver)
  - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
- [Cyagen Biosciences](/companies/apac-cyagen)
  - Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.
- [Cyagen Biosciences](/companies/cyagen)
  - Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.
- [Genevoyager (Wuhan) Co., Ltd.](/companies/genevoyager-2)
  - Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.
- [Noble Life Sciences](/companies/noblelifesci)
  - Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [ProBio](/companies/probio)
  - ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
- [SGVector](/companies/sgvector)
  - SGVector develops and manufactures viral vectors for cell and gene therapies, offering vector design, process development, scale-up, and analytical testing services with a scalable suspension-based platform.
- [Svar Life Science AB](/companies/svarlifescience)
  - Svar Life Science offers CRO services including bioanalytical testing, biomarker discovery, and GMP QC testing, alongside diagnostic services and cell manufacturing capabilities.
- [VIRSCIO](/companies/virscio)
  - Virscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.
- [uBriGene](/companies/ubrigene)
  - uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
